Advertisement
Journal Home
Search for

Volume 205, Issue 1, Pages 244-250 (July 2009)


View previous. 41 of 56 View next.

Vascular dysfunction and alteration of novel and classic cardiovascular risk factors in mothers of growth restricted offspring

Malini G. Kanagalingama, Scott M. NelsonaCorresponding Author Informationemail address, Dilys J. Freemana, William R. Ferrellb, Lynne Cherrye, Gordon D.O. Lowec, Ian A. Greerd, Naveed Sattarae

Received 4 August 2008; received in revised form 23 September 2008; accepted 8 October 2008. published online 20 November 2008.

Abstract 

Objective

Offspring and maternal birthweight are inversely associated with maternal cardiovascular disease. However, whether established or putative novel cardiovascular risk factors including vascular and metabolic function are disrupted in women who delivered small for gestational age (SGA) offspring is unknown.

Methods

Case control study with analysis of inflammatory, lipid, metabolic and haemostatic markers and microvascular function as assessed by laser Doppler iontophoresis 4 years after the index pregnancy in 28 mothers who delivered SGA offspring at term and 29 matched controls.

Results

Delivery of a SGA infant was associated with altered lipids [triglyceride median (IQR)mmol/l; control 0.64 (0.49–0.84); SGA 0.95 (0.67–0.95), p=0.012] [cholesterol:HDL ratio: control 2.64 (2.10–3.10); SGA 3.06 (2.65–3.89), p=0.013], systolic blood pressure [controlmmHg: 110 (108–118); SGA 120 (110–130), p=0.031], subclinical inflammation [CRPmg/l: control 0.7 (0.3–2.1); SGA 2.2 (1.2–4.0), p=0.002] [IL-6pg/ml: control 1.2 (0.8–1.4); SGA 1.5 (1.1–2.2), p=0.009] and endothelial activation [ICAM-1ng/ml: control 237.7 (210.0–279.4); SGA 283.1 (240.5–366.3), p=0.013], with differences robust to confounder adjustment. Endothelium dependent (p=0.003) and independent microvascular function (p<0.001) were also impaired in mothers of SGA offspring.

Conclusions

Mothers of term SGA offspring exhibit perturbation of metabolic and vascular function, which may underlie a lifelong trajectory of impaired health incorporating adverse perinatal and cardiovascular events.

a Reproductive and Maternal Medicine, University of Glasgow, 10 Alexandra Parade, Glasgow G31 2ER, United Kingdom

b Centre for Rheumatic Diseases, University of Glasgow, 10 Alexandra Parade, Glasgow G31 2ER, United Kingdom

c Division of Cardiovascular and Medical Sciences, University of Glasgow, Royal Infirmary, Glasgow G31 2ER, United Kingdom

d Hull and York Medical School, The University of York, Heslington, York YO10 5DD, United Kingdom

e British Heart Foundation Glasgow Cardiovascular Research Centre, University of Glasgow, 126 University Place, Glasgow G12 8TA, United Kingdom

Corresponding Author InformationCorresponding author at: Reproductive and Maternal Medicine, University of Glasgow, 3rd Floor Queen Elizabeth Building, 10 Alexandra Parade, Glasgow G31 2ER, United Kingdom. Tel.: +44 141 211 4705; fax: +44 141 552 0873.

PII: S0021-9150(08)00707-7

doi:10.1016/j.atherosclerosis.2008.10.006


View previous. 41 of 56 View next.

Advertisement